Product Gene Name
anti-MSH2 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for P43246
Specificity
Human MSH2. Reactivity with other species has not been investigated.
Form/Format
Purified antibody in Tris buffer, pH 7.3-7.7, 1% BSA, <0.1% sodium azide.
Immunogen
Recombinant human MSH2.
Preparation and Storage
Store at 2-8 degree C. Do not freeze.
Other Notes
Small volumes of anti-MSH2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-MSH2 antibody
MutS Homolog 2 (MSH2) is a protein involved in the mismatch-repair pathway. This protein is commonly associated with hereditary non-polyposis colorectal cancer, and mutations in this gene are correlated with the development of sporadic colorectal carcinoma. Expression levels of MSH2 are abnormally low in a high percentage of patients with microsatellite instability as well as endometrial and ovarian cancers. Anti-MSH2 antibody may be useful in the detection of the protein in a number of normal and neoplastic tissues and for identifying a loss of MSH2 in tumors that are microsatellite-unstable.
Product Categories/Family for anti-MSH2 antibody
Cancer Research Antibodies
Applications Tested/Suitable for anti-MSH2 antibody
Immunohistochemistry (IHC) Paraffin
Application Notes for anti-MSH2 antibody
Immunohistochemistry: use at a dilution of 1:100-1:200 on formalin-fixed, paraffin-embedded samples after heat-induced epitope retrieval at pH 6 for 10-30 minutes.
NCBI/Uniprot data below describe general gene information for MSH2. It may not necessarily be applicable to this product.
NCBI Accession #
P43246.1
[Other Products]
UniProt Primary Accession #
P43246
[Other Products]
UniProt Related Accession #
P43246[Other Products]
NCBI Official Full Name
DNA mismatch repair protein Msh2
NCBI Official Synonym Full Names
mutS homolog 2
NCBI Official Symbol
MSH2??[Similar Products]
NCBI Official Synonym Symbols
FCC1; COCA1; HNPCC; LCFS2; hMSH2; HNPCC1
??[Similar Products]
NCBI Protein Information
DNA mismatch repair protein Msh2
UniProt Protein Name
DNA mismatch repair protein Msh2
UniProt Synonym Protein Names
MutS protein homolog 2
Protein Family
DNA mismatch repair protein
UniProt Gene Name
MSH2??[Similar Products]
UniProt Synonym Gene Names
hMSH2??[Similar Products]
UniProt Entry Name
MSH2_HUMAN
NCBI Summary for MSH2
This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
UniProt Comments for MSH2
MSH2: Component of the post-replicative DNA mismatch repair system (MMR). Forms two different heterodimers: MutS alpha (MSH2- MSH6 heterodimer) and MutS beta (MSH2-MSH3 heterodimer) which binds to DNA mismatches thereby initiating DNA repair. When bound, heterodimers bend the DNA helix and shields approximately 20 base pairs. MutS alpha recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. MutS beta recognizes larger insertion-deletion loops up to 13 nucleotides long. After mismatch binding, MutS alpha or beta forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. In melanocytes may modulate both UV-B-induced cell cycle regulation and apoptosis. Heterodimer consisting of MSH2-MSH6 (MutS alpha) or MSH2- MSH3 (MutS beta). Both heterodimer form a ternary complex with MutL alpha (MLH1-PMS1). Interacts with EXO1. Part of the BRCA1- associated genome surveillance complex (BASC), which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2 and the RAD50-MRE11-NBS1 protein complex. This association could be a dynamic process changing throughout the cell cycle and within subnuclear domains. Interacts with ATR. Interacts with SLX4/BTBD12; this interaction is direct and links MutS beta to SLX4, a subunit of different structure-specific endonucleases. Interacts with SMARCAD1. Ubiquitously expressed. Belongs to the DNA mismatch repair MutS family.
Protein type: DNA-binding; Tumor suppressor
Chromosomal Location of Human Ortholog: 2p21
Cellular Component: nucleoplasm; nuclear chromosome; membrane; MutSalpha complex; MutSbeta complex
Molecular Function: protein C-terminus binding; DNA-dependent ATPase activity; double-strand/single-strand DNA junction binding; protein homodimerization activity; dinucleotide repeat insertion binding; single thymine insertion binding; ATPase activity; oxidized purine DNA binding; magnesium ion binding; ADP binding; protein kinase binding; mismatched DNA binding; loop DNA binding; centromeric DNA binding; Y-form DNA binding; protein binding; enzyme binding; four-way junction DNA binding; DNA binding; single guanine insertion binding; double-stranded DNA binding; guanine/thymine mispair binding; MutLalpha complex binding; dinucleotide insertion or deletion binding; single-stranded DNA binding; ATP binding
Biological Process: determination of ***** life span; maintenance of DNA repeat elements; germ cell development; positive regulation of helicase activity; double-strand break repair; negative regulation of neuron apoptosis; cell cycle arrest; DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis; response to X-ray; oxidative phosphorylation; negative regulation of DNA recombination; mismatch repair; postreplication repair; in utero embryonic development; male gonad development; somatic hypermutation of immunoglobulin genes; isotype switching; DNA repair; response to UV-B; meiotic mismatch repair; B cell mediated immunity; intra-S DNA damage checkpoint; B cell differentiation; meiotic gene conversion; somatic recombination of immunoglobulin gene segments; negative regulation of meiotic recombination
Disease: Muir-torre Syndrome; Mismatch Repair Cancer Syndrome; Lynch Syndrome I
Research Articles on MSH2
1. A, p.Val161Asp, found in a family fulfilling Amsterdam I criteria, Amsterdam II criteria and Bethesda guidelines, that on the basis of co-segregation with the disease, correlation with microsatellite instability, loss of MMR protein expression in tumour tissue and localization assay, is strongly suggested having a pathogenic role.">Study reports the case of a MSH2 missense variant, exon 3, c.482T>A, p.Val161Asp, found in a family fulfilling Amsterdam I criteria, Amsterdam II criteria and Bethesda guidelines, that on the basis of co-segregation with the disease, correlation with microsatellite instability, loss of MMR protein expression in tumour tissue and localization assay, is strongly suggested having a pathogenic role.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.